FDA Clearance Tracker · DEN100017
LIPFLOW THERMAL PULSATION SYSTEM (FORMERLY MANUAL MINI SYSTEM)
Last checked: Nov 19, 2026Latest source record: Jun 28, 2011 (this decision)Source: openFDAMethods & limitations
Decided
Jun 28, 2011
De Novo granted
Time to decision
323 days
Received Aug 9, 2010. Calendar days, including time FDA spent waiting on the applicant.
Pathway
De Novo
Post-NSE
Device class
Class II
The decision
- FDA number
- DEN100017
- Device name
- LIPFLOW THERMAL PULSATION SYSTEM (FORMERLY MANUAL MINI SYSTEM)
- Applicant
- Tearscience, Inc.
- Applicant location
- Morrisville, NC
- Received
- Aug 9, 2010
- Decided
- Jun 28, 2011
- Decision
- De Novo granted
- Submission type
- Post-NSE
Device type
- Device type
- Eyelid Thermal Pulsation System (ORZ)
- Device class
- Class II
- Regulation
- 21 CFR 886.5200
- Specialty
- Ophthalmology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- FDA granted this as a De Novo request, which means it created a new device type. There was no existing device to compare it to.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for DEN100017
- Decision summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
Other decisions for Tearscience, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K192623 · Decided Oct 22, 2019 · 29 days after receipt
Device type: Eyelid Thermal Pulsation System (ORZ) · Ophthalmology
K182506 · Decided Dec 10, 2018 · 89 days after receipt
Device type: Camera, Ophthalmic, Ac-Powered (HKI) · Ophthalmology
K161357 · Decided Nov 4, 2016 · 172 days after receipt
Device type: Eyelid Thermal Pulsation System (ORZ) · Ophthalmology
1 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.